In GBM there is increased expression of both Ang-1 and its antagonist angiopoietin-2 (Ang-2); Ang-2 is expressed by the ECs, whereas Ang-1 is expressed by the tumor cells and is not expressed by the tumor blood vessels [37]. This evidence concerns the gene ANGPT2 and glioblastoma.